BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback
PharmTech
AUGUST 12, 2025
SHOW MORE The company is not developing an mRNA vaccine, but had been using one as the control in a 10,000-subject Phase IIb trial. 5, 2025, Vaxart, a South San Francisco, Calif. The stop work order was issued despite the trial's Data Safety Monitoring Board allowing continuation without modification.
Let's personalize your content